Stockscreener 앱 받기
18.56
4.09%
0.73
시장 영업 전:
18.36
-0.20
-1.08%
전일 마감가:
$17.83
열려 있는:
$17.62
하루 거래량:
12.57M
Relative Volume:
3.09
시가총액:
$4.04B
수익:
$10.68M
순이익/손실:
$-272.71M
주가수익비율:
-11.86
EPS:
-1.565
순현금흐름:
$-213.38M
1주 성능:
+16.88%
1개월 성능:
+30.98%
6개월 성능:
+116.82%
1년 성능:
+459.04%
1일 변동 폭
$17.62
$18.75
1주일 범위
$16.14
$18.94
52주 변동 폭
$3.025
$18.94
릴레이 테라퓨틱스 Stock (RLAY) Company Profile
명칭
Relay Therapeutics Inc
전화
617-370-8837
주소
60 HAMPSHIRE STREET, CAMBRIDGE
Compare RLAY vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
18.56 | 4.04B | 10.68M | -272.71M | -213.38M | -1.565 |
VRTX
Vertex Pharmaceuticals Inc
|
491.34 | 124.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
632.90 | 66.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
887.18 | 55.17B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.37 | 38.90B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
182.08 | 38.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
릴레이 테라퓨틱스 Stock (RLAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-12-12 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-04-17 | 개시 | Wells Fargo | Equal Weight |
| 2024-09-10 | 재개 | Goldman | Buy |
| 2024-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-04-20 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-04-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 개시 | Raymond James | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-09-30 | 개시 | Barclays | Equal Weight |
| 2022-09-02 | 개시 | Stifel | Buy |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-07-21 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-08 | 개시 | JMP Securities | Mkt Outperform |
| 2020-11-05 | 개시 | H.C. Wainwright | Buy |
| 2020-08-10 | 개시 | Cowen | Outperform |
| 2020-08-10 | 개시 | Goldman | Buy |
| 2020-08-10 | 개시 | Guggenheim | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
모두보기
릴레이 테라퓨틱스 주식(RLAY)의 최신 뉴스
Why Is RLAY Stock Rising Today? - Stocktwits
RLAY stock declines pre-market after $175M offering — despite fresh bullish calls on Relay's zovegalisib - MSN
Relay Therapeutics, Inc. Actuals & Estimates (NASDAQ:RLAY) - TradingView
RLAY Forecast — Price Target — Prediction for 2027 - TradingView
Relay Therapeutics Stock Rockets 34% With 9-Day Winning Streak - Trefis
Relay Therapeutics (RLAY) Short Interest & Short Float | Updated Jun 2026 $RLAY - MarketBeat
Relay Therapeutics (RLAY) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Form 4 Relay Therapeutics Inc For: 24 June By Investing.com - Investing.com Nigeria
Relay Therapeutics president R&D sells $1.58m in stock By Investing.com - Investing.com Nigeria
Relay Therapeutics president R&D sells $1.58m in stock - Investing.com
Relay Therapeutics (RLAY) R&D chief exercises options and sells 93K shares - Stock Titan
Relay Therapeutics (NASDAQ: RLAY) CFO sells 187,163 shares after exercising options - Stock Titan
8-Day Rally Sends Relay Therapeutics Stock Up 29% - Trefis
Relay Therapeutics stock hits 52-week high at 17.54 USD - Investing.com UK
Relay Therapeutics stock hits 52-week high at 17.54 USD By Investing.com - Investing.com South Africa
Form 144 RELAY THERAPEUTICS For: 22 June By Investing.com - Investing.com Australia
Form 144 | Relay Therapeutics(RLAY.US) Officer Proposes to Sell 3.25 Million in Common Stocks - Moomoo
Donald A. (RLAY) files Form 144 to sell 93,456 shares on 06/22/2026 - Stock Titan
RLAY: Director Thomas Catinazzo executed 4 10b5-1 sales (Apr–May 2026) - Stock Titan
Relay Therapeutics StockAnalyst views and long-term strategy in focus - Ad-hoc-news.de
Analysts Are Bullish on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), Relay Therapeutics (RLAY) - The Globe and Mail
Top Smidcap Pick: TD Cowen Highlights Relay Therapeutics By Investing.com - Investing.com South Africa
Relay Therapeutics Inc (RLAY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Relay Therapeutics Inc (RLAY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Relay Therapeutics Inc (RLAY) Institutional Confidence - TradingKey
Relay Therapeutics Inc (RLAY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Relay Therapeutics Inc (RLAY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Relay Therapeutics Inc (RLAY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Relay Therapeutics Inc (RLAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Relay Therapeutics Inc (RLAY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Relay Therapeutics Q1 2026 earnings preview - MSN
Number of shareholders of Relay Therapeutics, Inc. – NASDAQ:RLAY - TradingView
Relay Therapeutics (RLAY) is One of the Best AI Driven Biotech Stocks, Here is Why - Insider Monkey
Relay Therapeutics Expands Authorized Shares at 2026 Meeting - The Globe and Mail
[Form 4] Relay Therapeutics, Inc. Insider Trading Activity - Stock Titan
Relay Therapeutics (RLAY) director granted options on 32,947 shares at $14.09 - Stock Titan
10 Best AI Driven Biotech Stocks to Invest In - Insider Monkey
Relay Therapeutics (NASDAQ: RLAY) ups authorized common stock to 450M - Stock Titan
Relay Therapeutics prices $275M public offering of common stock at $12/share - MSN
RLAY News | RELAY THERAPEUTICS INC (NASDAQ:RLAY) - ChartMill
Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL), Eli Lilly & Co (LLY) and Relay Therapeutics (RLAY) - The Globe and Mail
RLAY stock lights up on vascular anomalies treatment data boost – 60% of patients show sharp reduction in lesion volume - MSN
RLAY Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Relay Therapeutics Hits Day High with 10.1% Surge in Strong Intraday Performance - Markets Mojo
릴레이 테라퓨틱스 (RLAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.36%
자본화:
|
볼륨(24시간):